BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32301894)

  • 41. Impact of obesity on lipid profiles in middle-aged women.
    Maksvytis A; Stakisaitis D
    Medicina (Kaunas); 2004; 40(6):553-7. PubMed ID: 15208478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Metformin treatment of antipsychotic-induced dyslipidemia: analysis of two randomized, placebo-controlled trials].
    Yang Y; Wang X; Kang D; Long Y; Ou J; Guo W; Zhao J; Wu R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Oct; 44(10):1128-1136. PubMed ID: 31857506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of D-003 (10 mg/day) on biochemical parameters of bone remodelling in postmenopausal women: a randomized, double-blind study.
    Ceballos A; Mas R; Castaño G; Fernández L; Mendoza S; Menéndez R; González JJ; Illnait J; Gámez R; Mesa M; Fernández J
    Int J Clin Pharmacol Res; 2005; 25(4):175-86. PubMed ID: 16402634
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study.
    Hemelaar M; van der Mooren MJ; Mijatovic V; Bouman AA; Schijf CP; Kroeks MV; Franke HR; Kenemans P
    Menopause; 2003; 10(6):550-8. PubMed ID: 14627865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness of Chinese herbal medicine granules and traditional Chinese medicine-based psychotherapy for perimenopausal depression in Chinese women: a randomized controlled trial.
    Cao XJ; Huang XC; Wang X
    Menopause; 2019 Oct; 26(10):1193-1203. PubMed ID: 31513088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of high-intensity training on cardiovascular risk factors in premenopausal and postmenopausal women.
    Mandrup CM; Egelund J; Nyberg M; Lundberg Slingsby MH; Andersen CB; Løgstrup S; Bangsbo J; Suetta C; Stallknecht B; Hellsten Y
    Am J Obstet Gynecol; 2017 Apr; 216(4):384.e1-384.e11. PubMed ID: 28024987
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of obesity and body fat distribution on lipids and lipoproteins in nondiabetic American Indians: The Strong Heart Study.
    Hu D; Hannah J; Gray RS; Jablonski KA; Henderson JA; Robbins DC; Lee ET; Welty TK; Howard BV
    Obes Res; 2000 Sep; 8(6):411-21. PubMed ID: 11011907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-Atherosclerotic Effects of a Phytoestrogen-Rich Herbal Preparation in Postmenopausal Women.
    Myasoedova VA; Kirichenko TV; Melnichenko AA; Orekhova VA; Ravani A; Poggio P; Sobenin IA; Bobryshev YV; Orekhov AN
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of supplementation with high-selenium yeast on plasma lipids: a randomized trial.
    Rayman MP; Stranges S; Griffin BA; Pastor-Barriuso R; Guallar E
    Ann Intern Med; 2011 May; 154(10):656-65. PubMed ID: 21576533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The dual peroxisome proliferator-activated receptor alpha/gamma agonist tesaglitazar further improves the lipid profile in dyslipidemic subjects treated with atorvastatin.
    Tonstad S; Retterstøl K; Ose L; Ohman KP; Lindberg MB; Svensson M
    Metabolism; 2007 Sep; 56(9):1285-92. PubMed ID: 17697874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women.
    Love RR; Wiebe DA; Newcomb PA; Cameron L; Leventhal H; Jordan VC; Feyzi J; DeMets DL
    Ann Intern Med; 1991 Dec; 115(11):860-4. PubMed ID: 1952472
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].
    Liang DP; Yao XG; Li NF; Zhang DL; Guo YY; Lin L; Zhou L; Li WC; Yan ZT; Wang HM; Luo WL; Chang JH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 May; 45(5):440-3. PubMed ID: 21756789
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomized, double-blind, placebo-controlled comparison of the action of orlistat, fluvastatin, or both an anthropometric measurements, blood pressure, and lipid profile in obese patients with hypercholesterolemia prescribed a standardized diet.
    Derosa G; Mugellini A; Ciccarelli L; Fogari R
    Clin Ther; 2003 Apr; 25(4):1107-22. PubMed ID: 12809960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum lipid and apolipoprotein distributions in Hong Kong Chinese.
    Fong PC; Tam SC; Tai YT; Lau CP; Lee J; Sha YY
    J Epidemiol Community Health; 1994 Aug; 48(4):355-9. PubMed ID: 7964333
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials.
    Johnston CC; Bjarnason NH; Cohen FJ; Shah A; Lindsay R; Mitlak BH; Huster W; Draper MW; Harper KD; Heath H; Gennari C; Christiansen C; Arnaud CD; Delmas PD
    Arch Intern Med; 2000 Dec 11-25; 160(22):3444-50. PubMed ID: 11112238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia.
    Després JP; Golay A; Sjöström L;
    N Engl J Med; 2005 Nov; 353(20):2121-34. PubMed ID: 16291982
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
    Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial.
    Després JP; Ross R; Boka G; Alméras N; Lemieux I;
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):416-23. PubMed ID: 19112166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.